Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans

Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans ...
Seeking Alpha

Bristol-Myers Squibb Will Handle The Patent Cliff And Is Still Undervalued

Bristol-Myers Squibb remains a "Buy" despite recent price increases, with intrinsic value calculations showing the stock is still undervalued. The company faces risks from patent expirations but has ...

Jim Cramer on Bristol-Myers’ recent stock gain: “Unbelievable”

Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer commented on along with the recent macro rally. Cramer mentioned the stock during the episode, as he commented: “Then it might ...

Cytokinetics Takes On Bristol With Newly Approved Heart Drug

Cytokinetics Inc. won US approval for a drug to treat a deadly heart condition, posing a potential threat to sales of a ...
Forbes

Buy Bristol Myers Squibb Stock At $45?

Bristol-Myers Squibb (NYSE: BMY) has considerably lagged behind the overall market, with its stock decreasing by 20% this year, while the S&P 500 index has risen by 14%. This drop can be attributed in ...